Drugs

The growing occurrence of antimicrobial resistance (AMR) results in infections that are increasingly difficult to treat. These infections often necessitate prolonged hospitalizations, the use of pricier medications, specialized care solutions, and occasionally surgical treatments. This increased complexity in medical care […]

In an important online meeting aimed at uncovering business potential in the pharmaceutical industry, the Indian High Commission in Ulaanbaatar and the Pharmaceuticals Export Promotion Council of India (Pharmexcil) are strategizing a plan to fortify pharmaceutical relations through joint initiatives.

In honor of National Pharmacy Week (NPW), the Kerala chapter of the Indian Pharmaceutical Association (IPA) will host five regional events throughout the state, starting November 21. The festivities will commence in the state capital and conclude at Kottayam Medical

The Directorate General of Trade Remedies (DGTR), operating under the Ministry of Commerce & Industry, has announced a revised list of stakeholders engaged in the current anti-dumping examination related to the importation of polytetrafluoroethylene (PTFE) from China and Russia. Polytetrafluoroethylene,

### Policy Development for Safe Disposal Practices The Pharmaceuticals Department (DoP) is actively working on establishing a ‘Safe Disposal Policy’ aimed at effectively removing expired and unused medications from retail outlets and domestic spaces. To facilitate this, a specialized committee

Emcure Pharmaceuticals, a prominent player in the women’s healthcare sector, celebrated a remarkable achievement on World Diabetes Day by securing a place in the Asia Book of Records. The company orchestrated the largest virtual campaign focused on women’s diabetes awareness,

**Alnylam Pharmaceuticals, Renowned RNAi Therapy Leader, Unveils Promising Phase 1 Outcomes for Nucresiran** Alnylam Pharmaceuticals, a front-runner in the field of RNA interference (RNAi) therapeutics, disclosed the latest findings from its phase 1 research on nucresiran (previously known as ALN-TTRsc04),

Boston Scientific Corporation unveiled promising outcomes from the OPTION global clinical study involving the WATCHMAN FLX Left Atrial Appendage Closure (LAAC) Device, sharing three years of primary endpoint results. The study, which contrasted the device with initial oral anticoagulation (OAC)

BioCryst Pharmaceuticals, Inc., a leading biotech firm, revealed that Ireland’s Health Services Executive (HSE) has endorsed Orladeyo (berotralstat) for the regular prevention of repeated hereditary angioedema (HAE) attacks in suitable patients aged 12 and above. This endorsement enables Irish HAE

LIfT BioSciences, a leading-edge biotech firm gearing up to kick off clinical trials for its novel allogeneic innate cell therapy, has unveiled its latest expansion in manufacturing and clinical activities with the establishment of its Galway-based subsidiary, Eolaíocht Bhitheach LIfT